SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, KNW, ELEV, CRKN on Behalf of Shareholders
NEW YORK, June 9, 2025 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Flowserve Corporation (NYSE: FLS)'s merger with Chart Industries, Inc. Upon completion of the proposed transaction, Flowserve shareholders will own approximately 46.5% of the combined company. If you are a Flowserve shareholder, click here to learn more about your rights and options.
Know Labs, Inc. (NYSE American: KNW)'s sale to Goldeneye 1995 LLC. If you are a Know Labs shareholder, click here to learn more about your legal rights and options.
Elevation Oncology, Inc. (NASDAQ: ELEV)'s sale to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Elevation shareholders will receive $0.36 in cash per share, plus one non-tradeable contingent value right representing the right to receive: (i) 100% of the closing net cash in excess of $26.4 million; and (ii) 80% of any net proceeds received within five years following closing from any disposition of EO-1022 that occurs within one year following closing. If you are an Elevation shareholder, click here to learn more about your rights and options.
Crown Electrokinetics Corp. (OTCMKTS: CRKN)'s sale to Crown EK Acquisition LLC for $3.15 per share. If you are a Crown Electrokinetics shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.com https://www.halpersadeh.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
4 hours ago
- Malaysian Reserve
Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES, June 9, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz continues its investigation of EchoStar Corporation ('EchoStar' or the 'Company') (NASDAQ: SATS) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ECHOSTAR CORPORATION (SATS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 12, 2025, The Wall Street Journal reported that the Federal Communications Commission had notified EchoStar that it would be investigating the Company's compliance with federal requirements to build a nationwide 5G network. On this news, EchoStar's stock price fell $4.01, or 16.6%, to close at $20.18 per share on May 12, 2025, thereby injuring investors. Then, on May 30, 2025, EchoStar disclosed that it had 'elected not to make an approximately $326 million cash interest payment' in order to 'allow time for the FCC to provide the relief requested in [the Company's] Response' to the FCC's compliance investigation. On this news, EchoStar's stock price fell $2.44, or 12.1%, to close at $17.73 per share on May 30, 2025, thereby injuring investors further. Contact Us To Participate or Learn More: If you purchased EchoStar securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Call us at: 310-914-5007Email us at: info@ Visit our website at: Follow us for updates on Twitter at If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contact Us:The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz310-914-5007fcruz@
Malaysian Reserve
4 hours ago
- Malaysian Reserve
MegazoneCloud Wins 2025 Datadog Partner Network (DPN) Partner of the Year
SEOUL, South Korea, June 10, 2025 /PRNewswire/ — MegazoneCloud, a leading AI and cloud technology company has been recognized as the 2025 Datadog Partner Network (DPN) Partner of the Year for APAC by the monitoring and security platform for cloud applications Datadog, Inc. (NASDAQ: DDOG). The announcement comes ahead of the 8th annual DASH conference, hosted by Datadog in New York City. The DPN award winners were chosen based on a comprehensive set of criteria, including revenue growth, delivery capabilities across products and services, and overall contribution to customer success. Over the past year, MegazoneCloud has nearly doubled its Datadog-related revenue and expanded its dedicated technical team to more than 20 professionals. The company has also strengthened its capabilities across sales, engineering, technical support, marketing, and cost optimization—playing a key role in Datadog's growth in the Asia-Pacific region. Datadog recognized MegazoneCloud for its sustained business momentum and strong collaboration with customers, naming it the top-performing partner in APAC for 2025. 'We are pleased to recognize MegazoneCloud as our DPN Partner of the Year for APJ,' said Jarrod Buckley, Vice President, Channels & Alliances at Datadog. 'MegazoneCloud has made significant investments in their Datadog practices, consistently delivered successful outcomes for our joint customers, and achieved outstanding business results.' Inchul Hwang, Chief Revenue Officer at MegazoneCloud, added, 'We're honored to be recognized for the outcomes of our ongoing technical collaboration with Datadog, which has helped enterprises in Korea and globally enhance their monitoring and security capabilities in cloud environments. Moving forward, we'll continue to actively support our customers by breaking down silos and fostering a collaborative culture that drives the broad adoption of AI and cloud technologies—powered by Datadog's unified observability platform.' About MegazoneCloud MegazoneCloud is a leading AI and cloud-native company, home to over 2,000 cloud and AI technology experts. As a trusted digital transformation (DX) partner to more than 7,000 clients worldwide, MegazoneCloud empowers innovation and growth through strategic alliances with major global and domestic cloud service providers (CSPs). The company also collaborates with over 140 independent software vendors (ISVs) and offers a suite of proprietary cloud, AI, and security solutions. Under its vision of 'Transform Tomorrow, Together', MegazoneCloud is committed to building future-ready competitiveness for its customers—powered by cutting-edge technology, data, and the passion of its people. With local operations in nine countries, including Korea, North America, Japan, Southeast Asia, and Oceania, the company continues to grow alongside its global partners and clients. To learn more, visit: .
Malaysian Reserve
4 hours ago
- Malaysian Reserve
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zenas To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Zenas pursuant and/or traceable to Zenas' registration statement for the initial public offering held on or about September 13, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 10, 2025 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zenas BioPharma, Inc. ('Zenas' or the 'Company') (NASDAQ: ZBIO) and reminds investors of the June 16, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Zenas BioPharma materially overstated the amount of time it would be able to fund its operations using existing cash and expected net proceeds from the IPO; and (2) as a result, defendants' public statements were materially false and misleading at all relevant times and negligently prepared. When the true details entered the market, the lawsuit claims that investors suffered damages. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Zenas' conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Zenas BioPharma class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
